Showing results (421-430 of 434) with videos related to

Sort By:
Pageof 44
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 6, 2015
Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantationIan A Rowe, Damien C Tully, Matthew J Armstrong, et al.
Pharmacogenetics and Genomics|October 19, 2006
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group studyAlison A Motsinger, Marylyn D Ritchie, Robert W Shafer, et al.
The Journal of Infectious Diseases|November 4, 2005
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group StudyDavid W Haas, Laura M Smeaton, Robert W Shafer, et al.
Clinical Pharmacology and Therapeutics|March 2, 2026
Clinical Pharmacology Quality Assurance Program for Global HIV and Co-Infection Drug DevelopmentRobin DiFrancesco, Troy D Wood, Raymond Cha, et al.
The New England Journal of Medicine|December 12, 2003
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infectionRobert W Shafer, Laura M Smeaton, Gregory K Robbins, et al.
BMJ Open|September 2, 2025
Mental health disorders among people living with HIV in sub-Saharan Africa: a scoping review protocolWaheed Adeola Adedeji, Adeyinka Ganiyat Ishola, Olufisayo Elugbadebo, et al.
Journal of Mass Spectrometry : JMS|December 13, 2006
Ion trap mass spectrometry on a comet nucleus: the Ptolemy instrument and the Rosetta space missionJohn F J Todd, Simeon J Barber, Ian P Wright, et al.
Pediatrics|June 5, 2001
Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settingsW E Pelham, E M Gnagy, L Burrows-Maclean, et al.
The Journal of Clinical Investigation|October 5, 2020
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virusElias K Halvas, Kevin W Joseph, Leah D Brandt, et al.
Open Forum Infectious Diseases|March 7, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral TherapyCynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
Pageof 44